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 Pentagalloyl glucose stabilizes arterial elastic lamellae and preserves their integrity.
 Pentagalloyl glucose can penetrate the arterial wall in large AAA prone arteries from the inside.
 Pentagalloyl glucose, a potential new drug for stabilizing small abdominal aneurysms.a r t i c l e i n f o
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Background: The vast majority of abdominal aortic aneurysms found in screening programs are small,
and as no effective treatment exits, many will expand until surgery is indicated. Therefore, it remains
intriguing to develop a safe and low cost treatment of these small aneurysms, that is able to prevent or
delay their expansion.
In this study, we investigated whether intraluminal delivered pentagalloyl glucose (PGG) can impair the
early AAA development in a porcine model.
Methods: The infrarenal aorta was exposed in thirty pigs. Twenty underwent an elastase based AAA
inducing procedure and ten of these received an additional intraluminal PGG infusion. The ﬁnal 10 were
sham operated and served as controls.
Results: All pigs who only had an elastase infusion developed macroscopically expanding AAAs. In pigs
treated with an additional PGG infusion the growth rate of the AP-diameter rapidly returned to physi-
ological values as seen in the control group. In the elastase group, histology revealed more or less
complete resolution of the elastic lamellae in the media while they were more abundant, coherent and
structurally organized in the PGG group. The control group displayed normal physiological growth and
histology.
Conclusion: In our model, intraluminal delivered PGG is able to penetrate the aortic wall from the inside
and impair the early AAA development by stabilizing the elastic lamellae and preserving their integrity.
The principle holds a high clinical potential if it can be translated to human conditions, since it, if so,
potentially could represent a new drug for stabilizing small abdominal aneurysms.
© 2016 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
It is estimated that the global number of aortic aneurysm relatedKloster), lars.lund@rsyd.dk
.
er Ltd on behalf of IJS Publishingdeaths has increased from around a 100.000 in 1990 to around
152.000 in 2013, corresponding to a 52% increase [1].
The risk of developing an abdominal aortic aneurysm (AAA)
increases with age, and screening programs have revealed a prev-
alence of about 3.3e4.9% in European men aged 64e73 (highest in
the Caucasian subgroup) [2e5]. The MASS study found that the
majority (71%) of these aneurysms were small 3e4.4 cm. AGroup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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only recommended for aneurysms with an external
diameter  5.5 cm, aneurysms that expand >1 cm/year or become
symptomatic [6,7]. However, since smaller aneurysms (3.5e4 cm)
grow on average 2.5e3 mm/year with an exponentially increasing
growth rate of about 1.62 mm/year per 1-cm increase in aneurysm
diameter, many will eventually reach a size where surgery is indi-
cated. It has been found, that 3.5 cm and 4.5 cmAAAswould take on
average 6.2 years and 2.3 years respectively to reach 5.5 cm [7,8].
Despite intensive research into the complex multifactorial
etiopathogenesis of this degenerative disease, the exact mecha-
nisms involved are not yet fully understood and no effective
medical treatment exits.
Therefore, it remains intriguing to develop a safe and low cost
treatment (medically/minimal invasive) of these small aneurysms,
that is able to prevent or delay their expansion.
Increased proteolytic elastase and collagenase activity leading to
progressive degradation of the aortic walls connective tissue
resulting in decreased tensile strength, has been a key early ﬁnding
[9,10]. In vivo stabilization of infrarenal aortic elastin by means of
periadventitially delivered pentagalloyl glucose (PGG) in adult
male Sprague-Dawley rats, exposed to CaCl2-mediated aortic
elastin injury, has shown to prevent early AAA formation by bind-
ing to elastin and thereby preserving the integrity of the elastic
lamellae [11]. However, translation of experimental results in ro-
dents to humans has shown difﬁculties. Consequently, we hy-
pothesized, that intraluminal delivered PGG into the infrarenal
aortic segment of our previously described elastase based porcine
AAA model in the 30e38 kg weight range [12], also is able to
penetrate the arterial wall in large arteries from the inside and
stabilize the elastic lamellae, preserving their integrity and hereby
impair the early development of AAAs in our model.
2. Materials and methods
Thirty female Danish Landrace pigs in the 30e38 kg weight
range were divided into 3 groups of 10. Group A were subjected to
balloon dilatation, elastase and a juxtrarenal stenosing cuff (n ¼ 10,
mean weight 34 kg (range 31e38 kg)). Group B were subjected to
balloon dilatation, elastase, PGG and a juxtrarenal stenosing cuff
(n ¼ 10, meanweight 33 kg (range 31e35 Kg)), and control group C
underwent a sham procedure (n ¼ 10, mean weight 34 kg (range
30e38 kg)).
2.1. Anesthesia and surgical procedure
Anesthesia was induced by im. injection (mg/kg BW) of 1.25 mg
tiletamine, 1.25 mg zolazepam, 0.25 mg butorphanol, 1.25 mg ke-
tamine and 1.25 mg xylazine. After tracheal intubation, the animals
were placed in the supine position and ventilated with oxygen 4 L/
min and atm. air (1:1, v/v) and anesthesia was extended by
continuous intravenous infusion of 10 mg propofol and 25 mg fen-
tanyl per kg BW/h.
With the animals in the supine position a transabdominal ul-
trasound scan of the infrarenal aorta was performed in both the
transverse and longitudinal plane to measure the systolic preop-
erative external anterior-posterior diameter (AP0).
Through a midline longitudinal laparotomy and a retrocolic
prerenal transperitoneal approach the aorta was dissected from the
lowest renal artery to the trifurcation, whereafter the lumbars,
inferior mesenteric artery and the aorta itself were temporarily
clamped. Group C had the clamps removed after 30 min. In group A
and B a 2.5 mm arteriotomy in the aorta was made at the level of
the inferior mesenteric artery through which a 10mm 4 cm high-
pressure balloon catheter was placed and inﬂated for 5 min.Hereafter a curved beaded knop needle was introduced through
which 10 ml of porcine pancreatic elastase (Sigma-Aldrich
Denmark A/S, E1250-100MG, Type-I 4.0 units'/mg protein) was
gradually manually infused into the aortic lumen over 30min. Then
a 12 mm  4 cm high-pressure balloon catheter was introduced
and inﬂated for 5 min. After the second balloon dilatation the ﬁrst
ﬁve pigs in group B had 25 MG and the last ﬁve pigs in group B had
50MG of PGG (Penta-O-galloyl-b-D-glucose hydrate, Sigma-Aldrich
Denmark A/S, G7548, 96% (HPLC)) dissolved in 10 ml of isotonic
saline infused into the lumen and ﬂushed for 30 min. Hereafter the
arteriotomy was sutured and the aorta declamped. To establish
turbulent ﬂow in the infrarenal aortic segment of group A and B, a
stenosing nylon cable-tie strap (120 mm  5 mm) was placed as a
cuff around the aorta just below the renal arteries and narrowed
until a thrill indicating turbulent ﬂow in the infrarenal aortic
segment could be palpated and postoperatively be visualized by
Doppler sonography. Finally, the retroperitoneum and laparotomy
were closed.
2.2. Postoperative care
Postoperative the animals were monitored the subsequent 28
days. On the 3rd 7th 14th 21st and 28th postoperative days the pigs
were anaesthetized and the AP-diameter of the infrarenal aortawas
again measured using transabdominal ultrasound. Hereafter the
animals were euthanized with a lethal overdose of intravenous
phenobarbital and the infrarenal aortic segment was removed and
ﬁxed in 10% buffered formalin.
2.3. Histology
The specimens were sliced and stained with routine protocols
for human tissue for x100 and x400 microscopy with hematoxylin
and eosin stain, Verhoeff's stain for elastin and immunohisto-
chemical staining for human smooth muscle actin (that was found
to react satisfactory with tissue from pigs). Actin staining was done
in a Ventana autostainer using Actin, Muscle Speciﬁc Antibody
clone HHF35 from CELL MARQUE (6600 Sierra College Blvd. Rock-
lin, CA 95677 USA.) that labels smooth and striated muscle cells.
2.4. Statistics
Using mixed models for repeated measures a multivariate
analysis of variance (MANOVA) was performed to compare the
correlations of the aortic AP-diameters in the three groups over
time. In order to determine whether the slopes of the increase in
AP-diameter between the groupswere comparableWald chi^ 2 tests
were carried out. One-way ANOVAs were used to compare mean
weights between groups. Results were presented as means ± SD
and with 95% conﬁdence intervals P-values < 0.05 were considered
signiﬁcant.
3. Results
The three groups (A, B and C) were comparable in terms of mean
baseline weight Kg0 (P ¼ 0.45) and AP-diameter AP0 (P ¼ 0.36).
Throughout the experiment the mean weight did not differ
signiﬁcantly between the three groups (Table 1).
The mixed models MANOVA analysis revealed a signiﬁcant
difference in AP-development between the groups (P < 0.001)
(Table 1).
After 28 days all pigs in group A developed macroscopically
AAAs with a mean increase in AP-diameter to 16.26 ± 0.93 mm
equivalent to an increase of 57% ± 10.17 SD (Range 31%). In group B
the mean increase was lower and equal to 12.17 ± 0.13
Table 1
Schematic representation of the comparison between Group A, B and C.
Group A/Group B/Group C Day 0 Day 3 Day 7 Day 14 Day 21 Day 28
Mean weight, Kg ± SD
Group A 33.8 ± 2.44 34.3 ± 2.66 36.2 ± 1.99 40.7 ± 2.41 45.9 ± 2.69 50.4 ± 3.37
Group B 32.8 ± 1.62 34.2 ± 1.55 36.7 ± 1.42 40.3 ± 1.57 46.1 ± 1.52 51.8 ± 2.1
Group C 34.0 ± 2.58 34.4 ± 3.31 37.8 ± 2.10 42.2 ± 1.76 46.1 ± 3.05 51.2 ± 2.39
P values 0.45 0.99 0.16 0.09 0.98 0.51
Mean AP diameter, mm ± SD
Group A 10.36 ± 0.11 11.6 ± 0.18 12.85 ± 0.32 13.83 ± 0.44 14.74 ± 0.54 16.26 ± 0.93
Group B 10.28 ± 0.15 11.45 ± 0.15 11.57 ± 0.18 11.68 ± 0.12 11.83 ± 0.17 12.17 ± 0.13
Group C 10.37 ± 0.19 10.46 ± 0.13 10.64 ± 0.11 10.87 ± 0.19 11.06 ± 0.2 11.33 ± 0.13
P values 0.36 <0.001 <0.001 <0.001 <0.001 <0.001
Mean increase, %a ± SD
Group A 11.98 ± 2.62 24.04 ± 3.67 33.52 ± 5.19 42.32 ± 6.31 57.03 ± 10.17
Group B 11.39 ± 1.2 12.56 ± 1.55 13.64 ± 1.88 15.09 ± 1.92 18.41 ± 2.11
Group C 0.89 ± 1.59 2.63 ± 1.91 4.85 ± 1.85 6.69 ± 2.14 9.26 ± 1.37
Identical expansion rates/slopes Group A:B Group B:C Group A:B Group B:C
P values 0.45 <0.001 <0.001 0.06
a Mean increase, % with respect to the preoperative/Day 0 aortic AP-diameter.
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PGG dose given was 25 or 50 MG had no clear inﬂuence on the
resulting expansion. In control group C there were no signs of
developing aneurysms, as mean AP-diameter only increased to
11.33 ± 0.13 mm equivalent to 9.3% ± 1.37 SD (Range 3.5%) in
accordance with normal physiological growth (Table 1 and Fig 1).
The Wald chi^ 2 analysis revealed that group A and B had iden-
tical expansion rates from day 0 to day 3 (P¼ 0.45) but a signiﬁcant
reduction in the expansion rate in group B compared to group A
was seen from day 3 and onwards (P < 0.001) (Table 1 and Fig 2).
The ﬁnal mean AP-diameter (AP28) in group B was signiﬁcantly
larger than in group C (P < 0.001), but when adjusted for the im-
mediate mechanical dilating effect of the balloon dilatation sub-
jected to group B, by calculating the increase from the day 3 (AP3)
measurement, we saw no signiﬁcant difference in the expansion
between group B and C (0.72 mm ± 0.07 SD vs. 0.87 mm ± 0.04 SD).
After day 3 the Wald chi^ 2 test conﬁrmed identical slopes in group
B and C (P ¼ 0.06), indicating that the growth rate of the AP-Fig. 1. Notice the signiﬁcantly lager infrarenal AP-diameter (AP28) in group A (left
side) 28 days after surgery compared to the PGG treated group B aorta in the middle
(not opened) and control group C (right side). Please note that the shown specimens
representing group A and C are specimens from our previous study [12].diameter in group B had returned to physiological values after
day 3 (Table 1 and Fig. 2).
Microscopy of the removed aortic segments showed a preserved
endothelium in all groups and as previously described more or less
complete resolution of the elastic tissue in the tunica media in
group A. In small areas with partially preserved elastic lamellae (all
localized in the anti-luminal side of the tunica media) the ﬁbers
seemed disorganized, thinned and fragmented. In group B, the
elastic ﬁbers also seemed depleted in the luminal side of the media
but more abundant, coherent and structurally organized towards
the anti-luminal side, indicating possible preserved integrity with
elastic properties (Fig. 3). In group A and B the Immunoperoxidase
staining for smooth muscle actin revealed light to moderate
irregular scattered focal muscle atrophy in the tunica media.
Widespread calciﬁcations in the lamina elastica externa were
seen in group A and B, but only invasion of a few inﬂammatory cells
could be seen in the media and adventitia using a standard he-
matoxylin and eosin stain.
The tunica adventitia appeared largely unaffected. Group C
displayed normal histology in all layers (Fig. 3).Fig. 2. In group A a progressive aneurysmatic expansion of the infrarenal aortas were
seen. After the ﬁrst postoperative measurement the slope of the increase in AP-
diameter in group B and C were a like, indicating that the expansion rate of the AP-
diameter in Group B had returned to physiological values, as control group C only
showed physiological expansion/growth.
Fig. 3. Histological ﬁndings in the three groups. First, second and third column representing group A, B and C respectively (the luminal side to the right). Top row: Verhoeff's stain
for elastic tissue enlarged x100. While the elastic lamellae in group A are very dissolved, disorganized, thinned and fragmented, the ﬁbers in group B seem more abundant and
organized indicating preserved integrity, especially towards the anti-luminal side in the media. Bottom row: Immunoperoxidase staining for smooth muscle actin enlarged x400
(B2 x100) revealing light to moderate focal muscle atrophy towards the luminal side of the media in group A and B. Group C reveals normal aortic histology in both stains. Please
note that the shown specimens representing group A and C are specimens from our previous study [12].
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Subjecting the pigs for these three different types of operations
resulted in a signiﬁcant difference in AP-development. Group A
developed AAAs with a mean increase in AP-diameter of 57%. In the
PGG treated group B the growth rate rapidly returned to physio-
logical values and the ﬁnal increase was 18.4%. In group C the in-
crease in AP-diameter was only 9.3% in accordance with normal
physiological growth.
Histology revealed more or less complete resolution of the
elastic tissue in the tunica media in group A, but in group B they
were more abundant, coherent and structurally organized indi-
cating possible preserved integrity with elastic properties. Only a
few inﬂammatory cells could be seen in the media and adventitia.
Despite our open approach we have shown, that also endovas-
cular delivered PGG is able to penetrate the arterial wall and sta-
bilize the elastic lamellae from the inside in large AAA prone
arteries, and we believe this route is more clinically feasible.
As mentioned, this study is partly based upon data derived from
our previous described elastase based porcine AAA model [12],
where we operated and obtained the data from the pigs in group A
and C. This might be seen as a limitation, but due to animal ethics/
economic reasons, we chose to reuse these data and combine these
with the newly operated pigs in group B. However, we think the
groups and their data are still comparable, as we used pigs that
were comparable at baseline (same race and sex from the same
breeder, the same mean weight, the same surgeon doing the same
type of surgery and the same operative- and postoperative facilities
etc.).
Previous studies of the protective properties of PGG on the
elastic ﬁbers in AAA prone arteries have been carried out in a rat
model [11]. While the main results in that rat study and our study
are fairly alike, we believe that this pig model is more transform-
able to the human setting, due to the physical size of the vascula-
ture with similar arterial morphology.
In contrast to the rat study, we did not clarify as to how far PGG
also is able to limit AAA progression in established expanding an-
eurysms. This study would have been obvious since it, if so,potentially could have a great clinical impact, as such treatment
could hold the potential also to be beneﬁcial in larger aneurysms
not suitable to repair due to e.g. comorbidity or hostile anatomy.
Since we believe, such a study ideally should be carried out by
means of a totally endovascular approach, and since we did not
have the requisite facilities to perform such interventions, we chose
to concentrate on the impairment of early AAA formation.
The human AAA etiopathogenesis has in short been described as
a chronic inﬂammatory condition with a proteolytic imbalance.
Besides increased proteolytic elastase and collagenase activity, a
chronic inﬂammatory condition in the aortic wall, dominated by
macrophages, monocytes, lymphocytes, and plasma cells which
excrete cytotoxic mediators, with further proteolytic activities and
thus induces additional elastolytic breakdown and smooth muscle
apoptosis, is also an important characteristic that further weakens
the aortic wall [13e15]. Microscopy of a specimen removed 24 h
after surgery (intended to be in group A but excluded due to lower
limp paralysis), revealed a severe inﬂammatory response in the
media with invasion of inﬂammatory cells.
In this study however, only very sparse inﬂammatory changes
could be detected at the time of harvest on the 28th postoperative
day in group A and B. Attenuating inﬂammation over time is in
contrast to the nature of human AAAs, which could imply, that the
porcine aorta has a partial healing potential. This theory, is sup-
ported by the ﬁndings of Hynecek et al. [16], who in a similar
porcine model of AAAs reported a decrease in inﬂammation,
reendothelialization of the damaged intimal surface, recovery of
smooth muscle cells, but no sign of recovery or reorganization of
the damaged elastic ﬁbers after 6 weeks. Similar ﬁndings of such a
self-healing phenomenon has been reported in elastase based
rabbit aneurysm models [17e19] and has been described as the
“response to injury” hypothesis. In these models, smooth muscle
cell proliferation and elastin regeneration occurs after AAA induc-
tion, and even gradual aneurysm shrinkage with return of near
normal diameter by day 90 has been reported [20].
Whether regeneration of the elastic lamellae, in an induced
porcine AAA also is possible after smooth muscle recovery, remains
to be investigated by an even longer follow-up time than 6 weeks.
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possible within the ﬁrst 6 weeks, we believe that the infused PGG
has exercised an immediate stabilizing effect on the damaged ﬁbers
and not resulted in any accelerated healing. Therefore, PGG may
only stabilize the aortic wall and prevent or delay further acceler-
ated aneurysmal dilatation due to progressive elastic deterioration
and not reverse the disease itself.
As our AAAmodel doesn't display chronic inﬂammation, further
investigations into the natural history/pathogenesis of AAAs and
the potential treatment options that involves these inﬂammatory
mechanisms, and then translating the ﬁndings to human condi-
tions using this model may be biased, as it does not look to be
pathogenically identical. However, as Jason et al. [11] demonstrated
that PGG binds directly to the elastic lamellae and hereby
strengthens the aneurysm wall itself without affecting the in-
ﬂammatory response, and as we have demonstrated that PGG also
impairs the early AAA development in our model without being
dependent on an inﬂammatory inﬁltrate, we believe that PGG ex-
erts its effect independently of these inﬂammatory mechanisms.
Consequently, we believe that endovascular PGG infusion impairs
the early development of AAAs in our model by preserving the
integrity of elastic lamellae, making the aortic wall resistant to both
enzymatic degradation and increased shear stress, and that PDD
therefore might be considered tested in humans, despite our
models general lack of applicability to human AAAs regarding the
inﬂammatory pathophysiology.
However, questions to be answered before that; Although PGG is
found naturally as a polyphenolic tannin in e.g. pomegranates,
whose juice/seeds is known for a wide range of therapeutic/pre-
ventive properties [21], it is not knownwhat side effects may occur
when it in its pure form is added directly into the circulation (will it
stiffen the entire arterial system or cause any organ damage etc.),
therefore further studies are needed to clarify these issues. As a
consequence, PGG may not be given as a systemic drug, and has to
be delivered locally. Today, drug-coated balloons (DCBs) and drug-
eluting stents (DESs) exists for the treatment of atherosclerotic
peripheral and coronary artery disease [22,23], and such devises
could potentially be developed for aortic dimensions. Tensiometric
measurements of human AAA walls may then be needed to clarify
at which pressure the drug will be eluted. The next question would
be, whether 30 min of perfusion with PGG is needed or whether it
can be reduced considerably, as 30minwill require some “clamping
time” and thus result in hemodynamic cardiac changes causing
increased risks of complications. In addition, will it diffuse through
a mural thrombus? We believe so, as the physiological transport in
the aortic wall, owing to the pressure generated in the bloodstream,
occurs mainly by radial/orthogonal hydraulic conductance, result-
ing in a centrifugal convection that transports soluble substances
from the blood/lumen outwards through the arterial wall to the
adventitia [24], a transport which is probably enhanced at the site
of an AAA due to the damaged endothelial and medial layers. Such
convection of PGG through a thrombus is most likely plausible due
to the high permeability of macromolecules through the thrombus
due to its network of interconnected canaliculi [25].Ethical approval
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